Skip to main content
Premium Trial:

Request an Annual Quote

Short Reads: Apr 1, 2004


Paulette Dillon joins Celera Genomics as chief business officer. She will work with CSO Robert Booth and report to Kathy Ordoñez, president. Dillon last worked as market and business development VP for Exelixis Pharmaceuticals.


Thomas Schweins is the new corporate strategy VP for Qiagen, leaving his post at the Boston Consulting Group.


GeneGo hires in Sean Ekins as VP for computational biology. Ekins comes from Concurrent Pharmaceuticals, where he was associate director for computational drug discovery.


Edward Albini resigns as chief financial officer for Lynx Therapeutics. Susan Berland, a consultant and former CFO of DNA Sciences, will fill the position until a replacement is found.


Exact Sciences also says farewell to its CFO: John McCarthy leaves his post to pursue other opportunities, the company says.


Invitrogen announces two new hires: Michael Stapleton, previously COO of Accelrys, comes aboard as general manager and vice president. Vivien Bonazzi, who comes from directing product development and scientific management at Celera Genomics, is the new director of research and development.


NimbleGen Systems hires Dan Clutter, who has worked at PerkinElmer, ABI, and Celera, among others, as vice president of sales. NimbleGen also announces that Emile Nuwaysir, one of the company’s first employees, will become vice president of business development.


DNAStar’s new VP and general manager is Tom Schwei, who has worked at Promega, PanVera, and Invitrogen.


Robert Voelkner heads to LIMS provider InnaPhase as director of business development. Voelkner was last seen at Thermo Electron, where he was VP of sales for the informatics department.


DNA Phenomics, a genomics-based diagnostic and discovery company based in Kuala Lumpur, Malaysia, appoints biochemist Shaharuddin Datuk Aziz as chief scientific officer and Jerry Wicks as chief technology officer. Wicks will also remain in his current post as president of Web-application firm Senecio Software.


Having previously served as counsel at 724 Solutions and Compaq Computer, David Reiter becomes general counsel and VP for Luminex.


Software and consulting firm Pharsight brings on James Bosley as senior director of product management.


The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.